Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 136 AL 150

Are Oligodendrocytes the Culprits or Victims in Alzheimer's Disease

Rapaka D, Saniotis A, Henneberg M, Bitra VR.

Physiol Res. 2025 Apr 30;74(2):219-231. doi: 10.33549/physiolres.935451.

A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences

Chavez-López LM, Silvestre-Martínez JH, Del Carmen Lugo-Ibarra K, Castro-Ceseña AB.

Brain Res. 2025 Sep 1;1862:149718. doi: 10.1016/j.brainres.2025.149718. Epub 2025 May 26.

Bridging systemic metabolic dysfunction and Alzheimer's disease: the liver interface

Song D, Li Y, Yang LL, Luo YX, Yao XQ.

Mol Neurodegener. 2025 May 28;20(1):61. doi: 10.1186/s13024-025-00849-6.

Melatonin Supplementation in Alzheimer's disease: The Potential Role in Neurogenesis

Ebrahimi R, Faramarzi A, Salarvandian S, Zarei R, Heidari M, Salehian F, Esmaeilpour K.

Mol Neurobiol. 2025 Nov;62(11):14987-15009. doi: 10.1007/s12035-025-05095-x. Epub 2025 May 29.

Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions

Li L, Wang Y, Feng Q, Ma C, He C, Wan W, Tang L.

J Alzheimers Dis. 2025 Jun;105(4):1222-1238. doi: 10.1177/13872877251335572. Epub 2025 Jun 2.

MicroRNA biosensors for detection of Alzheimer's disease

Vafadar A, Younesi M, Maddahi ME, Ehtiati S, Kazerouni HM, Khalaj FM, Ghasemi H, Savardashtaki A.

Clin Chim Acta. 2025 Aug 15;576:120410. doi: 10.1016/j.cca.2025.120410. Epub 2025 May 31.

The many connections of UFMylation with Alzheimer's disease: a comprehensive review

Yan T, Clarkson BD, Lou Z, Springer W, Fiesel FC.

Mol Neurodegener. 2025 Jun 4;20(1):66. doi: 10.1186/s13024-025-00855-8.

Targeting together cholinesterases and serotonin reuptake against Alzheimer's disease

Guiselin T, Lecoutey C, Rochais C, Dallemagne P.

J Pharm Pharmacol. 2025 Oct 1;77(10):1303-1318. doi: 10.1093/jpp/rgaf041.

Signs of Alzheimer's Disease: Tied to Aging

Chen J, Zhu Z, Xu Y.

Int J Mol Sci. 2025 May 22;26(11):4974. doi: 10.3390/ijms26114974.

Serotonergic Regulation in Alzheimer's Disease

Dolgacheva LP, Zinchenko VP, Nadeev AD, Goncharov NV.

Int J Mol Sci. 2025 May 29;26(11):5218. doi: 10.3390/ijms26115218.

Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer's Disease

Khan MA.

Int J Mol Sci. 2025 May 30;26(11):5283. doi: 10.3390/ijms26115283.

Preclinical Evidence of Withania somnifera and Cordyceps spp.: Neuroprotective Properties for the Management of Alzheimer's Disease

Tancreda G, Ravera S, Panfoli I.

Int J Mol Sci. 2025 Jun 4;26(11):5403. doi: 10.3390/ijms26115403.

Advancing the science of recruitment for Alzheimer's clinical trials: Challenges and opportunities

Aisen P, Peneva D, Manetas MA, Jacobson M, Goldman D, Bose N, Ferrell PB, Vu VK, Raman R.

J Prev Alzheimers Dis. 2025 Aug;12(7):100230. doi: 10.1016/j.tjpad.2025.100230. Epub 2025 Jun 12.

Memory Gate Controlled by Contexts: Potential Key Structure That Could Link Small Associative Failures With Severe Cognitive Disorders

Mizraji E, Lin J, Pomi A.

Bioessays. 2025 Aug;47(8):e70032. doi: 10.1002/bies.70032. Epub 2025 Jun 16.

Bilirubin: a game-changer in alzheimer's therapy? Unveiling its neuroprotective and disease-modifying potential

Sidhu RK, Mittal Y, Aran KR.

Metab Brain Dis. 2025 Jun 16;40(6):224. doi: 10.1007/s11011-025-01653-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias